[go: up one dir, main page]

AU4005697A - Agonist-dependent internalization of human somatostatin receptors types 1-5 - Google Patents

Agonist-dependent internalization of human somatostatin receptors types 1-5

Info

Publication number
AU4005697A
AU4005697A AU40056/97A AU4005697A AU4005697A AU 4005697 A AU4005697 A AU 4005697A AU 40056/97 A AU40056/97 A AU 40056/97A AU 4005697 A AU4005697 A AU 4005697A AU 4005697 A AU4005697 A AU 4005697A
Authority
AU
Australia
Prior art keywords
agonist
somatostatin receptors
human somatostatin
dependent internalization
receptors types
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40056/97A
Other languages
English (en)
Inventor
Nedim Hukovic
Ujendra Kumar
Rosemarie Panetta
Yogesh C. Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patel Cell & Receptor Technologies Inc
Original Assignee
Patel Cell & Receptor Technolo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patel Cell & Receptor Technolo filed Critical Patel Cell & Receptor Technolo
Publication of AU4005697A publication Critical patent/AU4005697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU40056/97A 1996-08-23 1997-08-20 Agonist-dependent internalization of human somatostatin receptors types 1-5 Abandoned AU4005697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2440996P 1996-08-23 1996-08-23
US60024409 1996-08-23
PCT/CA1997/000592 WO1998008100A1 (fr) 1996-08-23 1997-08-20 Internalisation, dependante des agonistes, des recepteurs de la somatostatine humaine de type 1-5

Publications (1)

Publication Number Publication Date
AU4005697A true AU4005697A (en) 1998-03-06

Family

ID=21820452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40056/97A Abandoned AU4005697A (en) 1996-08-23 1997-08-20 Agonist-dependent internalization of human somatostatin receptors types 1-5

Country Status (4)

Country Link
EP (1) EP0925506A1 (fr)
AU (1) AU4005697A (fr)
CA (1) CA2264007A1 (fr)
WO (1) WO1998008100A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070108953A (ko) 2003-04-22 2007-11-13 소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. 펩타이드 벡터
US20060105393A1 (en) * 2004-10-25 2006-05-18 Christian Apfel Ligand-receptor tracking assays

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727041A (en) * 1986-04-16 1988-02-23 Chaovanee Aroonsakul Method of diagnosing Alzheimer's disease
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses

Also Published As

Publication number Publication date
EP0925506A1 (fr) 1999-06-30
WO1998008100A1 (fr) 1998-02-26
CA2264007A1 (fr) 1998-02-26

Similar Documents

Publication Publication Date Title
AU2363695A (en) Human tumor necrosis factor receptors
AU6030398A (en) Human proteins
AU7830398A (en) Human tumor necrosis factor receptor tr9
AU9805398A (en) Novel human egf receptors and use thereof
AU1553199A (en) Antagonists of g-protein-coupled receptor
AU6035999A (en) Human gpcr proteins
AU2236895A (en) Human g-protein coupled receptors
AU1968400A (en) Human vanilloid receptors and their uses
AU6232300A (en) Receptors and associated proteins
AU3223397A (en) Specific co-activator for human androgen receptor
AU1535699A (en) Novel receptors opg-2
AU6007798A (en) Insect ecdysteroid receptors
AU3388597A (en) Human type ii gonadotropin-releasing hormone receptor
AU9017598A (en) Human frezzled-like protein
AU8921198A (en) New human g-protein coupled receptor
AU6035398A (en) Human c5a-like receptor
AU5918598A (en) Human extracellular matrix-1
AU8665898A (en) Human longevity-assurance protein homologs
AU4753496A (en) Human g-protein coupled receptor
AU4005697A (en) Agonist-dependent internalization of human somatostatin receptors types 1-5
AU7583898A (en) Gdnf receptors
AU7647798A (en) Preparation of mibefradil i
AU4849299A (en) Human emr1-like g protein coupled receptor
AU1645599A (en) Human matrilin-3
AU8019494A (en) Human endothelin-bombesin receptor